More
    Guided Solutions - Connecting Talent With Innovation/div>

    Recor Medical receives FDA approval for hypertension treatment system

    The system has been approved after receiving a favourable recommendation from the FDA Advisory Committee Panel. Recor Medical, along with its parent company Otsuka Medical...

    AliveDx secures IVDR certification for sites in UK and Switzerland

    Two manufacturing facilities across Europe have received IVDR certification following the transition away from IVDD. Switzerland-based vitro diagnostic company AliveDx has announced it received an...

    Smileyscope secures FDA clearance for VR device in acute pain relief

    The device, which replaces needle pricks with fish nibbles, is part of a global VR market estimated to be worth $51bn by 2030. The US...

    Neurovalens wins FDA clearance for insomnia device

    The US Food and Drug Administration (FDA) has granted 510(k) clearance to Neurovalens’s Modius Sleep, a device used to treat chronic insomnia. The Belfast-based company...

    Creo Medical to launch UltraSlim device 18 months ahead of schedule

    Creo Medical’s Speedboat UltraSlim to hit the market in early 2024 following guidance from EU regulator. UK-based company Creo Medical is planning the launch of...

    Chordate Medical Secures EU Trademark Registration for Ozilia®

    Chordate Medical has obtained the registration of the trademark Ozilia® in the EU from EUIPO (EU Intellectual Property Office) in trademark classes 9 and...

    Positive six-month follow-up results for Recor’s renal denervation system

    Recor Medical has followed up its US Food and Drug Administration (FDA) approval of its Paradise ultrasound renal denervation system earlier this year with...

    FDA approves breast reconstruction trial using human ADM

    The US Food and Drug Administration (FDA) has approved MTF Biologics’s trial using the FlexHD Pliable device in breast reconstruction after the agency granted...

    Medtronic receives FDA approval for extravascular defibrillator to treat abnormal heart rhythms, sudden cardiac arrest

    DUBLIN, Oct. 23, 2023 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, has received U.S. Food and Drug Administration (FDA) approval for the Aurora EV-ICD™...

    Latest articles